Lower Urinary Tract Symptoms in Transmasculine Patients Undergoing Metoidioplasty and Their Acceptability of Pelvic Floor Muscle Training Assessed by a Pelvic, Obstetric and Gynaecological Physiotherapist

Launched by CHELSEA AND WESTMINSTER NHS FOUNDATION TRUST · Apr 25, 2025

Keywords

ClinConnect Summary

This clinical trial is studying how well pelvic floor muscle training (PFMT) works for transmasculine patients who are undergoing a type of surgery called metoidioplasty. The goal is to find out if these patients find PFMT helpful for managing lower urinary tract symptoms, which can include issues like frequent urination, urgency, or trouble starting to urinate. The researchers will be asking about participants' experiences with PFMT through questionnaires and other assessments during the study.

To participate in this trial, patients need to be at least 18 years old, have been living as their gender identity for at least 12 months, and must be receiving testosterone therapy for over a year. They should also be referred for surgery and undergoing metoidioplasty or phalloplasty. Participants can expect to share their thoughts and experiences regarding PFMT, helping researchers understand its acceptability and effectiveness in this specific group. The study is set to begin recruiting participants in 2025 and will involve about 50 individuals.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Have capacity to consent.
• • Diagnosis of gender dysphoria and have lived in a gender role that is congruent to their gender identity for minimum of 12 months.
• • Transmasculine patients referred to CCGS for masculinising lower genital reconstructive surgery having received two signatures confirming suitability for reconstructive surgery.
• • Undergoing metoidioplasty/phalloplasty.
• • Age \>17 years old.
• • On systemic testosterone therapy for more than 12 months.
• Exclusion Criteria:
• • Age less than 18 years.
• • Not undergoing metoidioplasty/phalloplasty.